Bhagat Vikas, Pandit Rahul A, Ambapurkar Shwetha, Sengar Manju, Kulkarni Atul P
Department of Critical Care Medicine, Aster Hospital, Dubai, UAE.
Fortis Hospital, Mumbai, Maharashtra, India.
Indian J Crit Care Med. 2021 Jan;25(1):67-76. doi: 10.5005/jp-journals-10071-23439.
The number of allogeneic solid organ and bone marrow transplants is increasing all over the world. To prevent transplant rejection and treat acute rejection of transplant, immunosuppressant drugs are used. The outcomes of solid organ transplants have dramatically improved over last 30 years, due to availability of multiple immunosuppressive agents, with varied mechanisms of action. The use of intense immunosuppression makes the individual having undergone solid organ transplant at the risk of several serious infections, which may prove fatal. To prevent and treat these infections (when they occur), patients are often given antimicrobial prophylaxis and therapy. The use of antimicrobials can interfere with the metabolism of the immunosuppressants, and may put the patient at risk of developing severe adverse effects due to unwanted increase or decrease in the serum levels of immunosuppressive agents. Knowledge of these interactions is essential for successful management of solid organ transplant patients. We therefore decided to review the literature and present the interactions that commonly occur between these two life-saving groups of drugs. Bhagat V, Pandit RA, Ambapurkar S, Sengar M, Kulkarni AP. Drug Interactions between Antimicrobial and Immunosuppressive Agents in Solid Organ Transplant Recipients. Indian J Crit Care Med 2021;25(1):67-76.
全世界异体实体器官和骨髓移植的数量正在增加。为预防移植排斥反应和治疗移植后的急性排斥反应,人们使用免疫抑制药物。在过去30年里,由于有多种作用机制各异的免疫抑制剂,实体器官移植的效果有了显著改善。使用强效免疫抑制使接受实体器官移植的个体面临多种严重感染的风险,这些感染可能是致命的。为预防和治疗这些感染(当感染发生时),患者通常会接受抗菌预防和治疗。抗菌药物的使用可能会干扰免疫抑制剂的代谢,并可能因免疫抑制剂血清水平意外升高或降低而使患者面临出现严重不良反应的风险。了解这些相互作用对于成功管理实体器官移植患者至关重要。因此,我们决定回顾文献并介绍这两类挽救生命的药物之间常见的相互作用。 巴加特V、潘迪特RA、安巴普尔卡S、森加尔M、库尔卡尼AP。实体器官移植受者中抗菌药物与免疫抑制药物之间的药物相互作用。《印度重症监护医学杂志》2021年;25(1):67 - 76。